Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price negotiations that were put in place by the Biden administration's Inflation Reduction Act (IRA).

"They need to fix [the IRA]," Eli Lilly CEO Dave Ricks told Bloomberg at the JPMorgan Healthcare Conference in San Francisco.

The results of the first round of IRA negotiations , announced in August, saw the list prices of 10 high-cost drugs get slashed by as much as 79 percent. Collectively, the negotiated prices are estimated to save seniors $1.5 billion in out-of-pocket costs in 2026, when the prices go into effect. The savings will likely be well received, given that KFF polling has found that over a quarter of Americans struggle to afford prescription medications , and 31 percent say they haven't taken medicines as prescribed due to costs.

Read full article

Comments

Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price negotiations that were put in place by the Biden administration's Inflation Reduction Act (IRA).

"They need to fix [the IRA]," Eli Lilly CEO Dave Ricks told Bloomberg at the JPMorgan Healthcare Conference in San Francisco.

The results of the first round of IRA negotiations , announced in August, saw the list prices of 10 high-cost drugs get slashed by as much as 79 percent. Collectively, the negotiated prices are estimated to save seniors $1.5 billion in out-of-pocket costs in 2026, when the prices go into effect. The savings will likely be well received, given that KFF polling has found that over a quarter of Americans struggle to afford prescription medications , and 31 percent say they haven't taken medicines as prescribed due to costs.

Read full article

Comments

Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price negotiations that were put in place by the Biden administration's Inflation Reduction Act (IRA).

"They need to fix [the IRA]," Eli Lilly CEO Dave Ricks told Bloomberg at the JPMorgan Healthcare Conference in San Francisco.

The results of the first round of IRA negotiations , announced in August, saw the list prices of 10 high-cost drugs get slashed by as much as 79 percent. Collectively, the negotiated prices are estimated to save seniors $1.5 billion in out-of-pocket costs in 2026, when the prices go into effect. The savings will likely be well received, given that KFF polling has found that over a quarter of Americans struggle to afford prescription medications , and 31 percent say they haven't taken medicines as prescribed due to costs.

Read full article

Comments

OpenAI is making ChatGPT work a little more like older digital assistants with a new feature called Tasks, as reported by TechCrunch and others.

Currently in beta, Tasks allows users to direct the chatbot to send reminders or to generate responses to specific prompts at certain times; recurring tasks are also supported.

The feature is available to Plus, Team, and Pro subscribers starting today, while free users don't have access.

Read full article

Comments

OpenAI is making ChatGPT work a little more like older digital assistants with a new feature called Tasks, as reported by TechCrunch and others.

Currently in beta, Tasks allows users to direct the chatbot to send reminders or to generate responses to specific prompts at certain times; recurring tasks are also supported.

The feature is available to Plus, Team, and Pro subscribers starting today, while free users don't have access.

Read full article

Comments

OpenAI is making ChatGPT work a little more like older digital assistants with a new feature called Tasks, as reported by TechCrunch and others.

Currently in beta, Tasks allows users to direct the chatbot to send reminders or to generate responses to specific prompts at certain times; recurring tasks are also supported.

The feature is available to Plus, Team, and Pro subscribers starting today, while free users don't have access.

Read full article

Comments

Microsoft CEO Satya Nadella has announced a dramatic restructuring of the company's engineering organization—all around pivoting the company's focus to developing the tools that will underpin agentic AI.

Dubbed "CoreAI - Platform and Tools," the new division rolls the existing AI platform team and the previous developer division (which is responsible for everything from .NET to Visual Studio) along with some other teams into one big group.

As for what this group will be doing specifically, it's basically everything that's mission critical to Microsoft in 2025, as Nadella tells it:

Read full article

Comments

Microsoft CEO Satya Nadella has announced a dramatic restructuring of the company's engineering organization—all around pivoting the company's focus to developing the tools that will underpin agentic AI.

Dubbed "CoreAI - Platform and Tools," the new division rolls the existing AI platform team and the previous developer division (which is responsible for everything from .NET to Visual Studio) along with some other teams into one big group.

As for what this group will be doing specifically, it's basically everything that's mission critical to Microsoft in 2025, as Nadella tells it:

Read full article

Comments

Microsoft CEO Satya Nadella has announced a dramatic restructuring of the company's engineering organization—all around pivoting the company's focus to developing the tools that will underpin agentic AI.

Dubbed "CoreAI - Platform and Tools," the new division rolls the existing AI platform team and the previous developer division (which is responsible for everything from .NET to Visual Studio) along with some other teams into one big group.

As for what this group will be doing specifically, it's basically everything that's mission critical to Microsoft in 2025, as Nadella tells it:

Read full article

Comments